baber/WOPTO huggingface dataset:
Patent CA-2511736-A1 (CA)
Title: Smoking kit for customizing a tobacco product
Inventor: GOMEZ REMBERTO ANDRES ESTRELLA
IPC: A24D1/00
Filed: 2005-07-07
Abstract: Smoking kit and techniques for purveying a tobacco product are provided. The kit includes at least one pre-finished tobacco product. The kit further includes at least one wrapping sheet supported by the pre-finished product in a predetermined shape. The wrapping sheet may be configured to exhibit a perceptible olfacto-gustatory characteristic. A consumer can optionally roll the wrapping sheet around the pre-finished product to create a consumer-customized smoking product influenced by the olfacto-gustatory characteristic of the wrapping sheet. Another option may be for the consumer to smoke the pre-finished tobacco product as is.
Patent CA-2512515-A1 (CA)
Title: Super-antigen fusion proteins and the use thereof
Inventor: LIAO CHAO-WE
IPC: C07K14/165
Filed: 2005-07-20
Abstract: The present invention relates to a super-antigen fusion protein, comprising: a peptide fragment encoding a partial SARS E2 spike protein; and a translocating peptide fragment for transporting a protein into a cell and translocating the protein in cytosol; wherein, the amino acid of the peptide fragment encoding the partial SARS E2 spike protein includes SEQ      ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4. The present invention further relates to DNA sequences encoding the partial SARS E2 spike protein includes SEQ ID NO.5, SEQ ID NO.6, SEQ ID NO.7, or SEQ      ID NO.8; wherein the DNA sequences are able to express specific proteins in an E. Coli expression system.
Patent CA-2513269-A1 (CA)
Inventor: DAUTEL HANS
IPC: A01N65/12
Filed: 2004-01-05
Abstract: Utilisation d'un constituant repoussant les arthropodes, de la classe des pyréthroïdes / pyréthrine, en combinaison avec un agoniste du récepteur nicotinique de l'acétylcholine d'arthropodes pour repousser de manière efficace et à long terme les arthropodes, en particulier sur les animaux.
Patent CA-2514710-A1 (CA)
Inventor: BAUGHMAN JOHN MICHAEL
IPC: A23L29/262
Filed: 2004-02-05
Abstract: A non-fat creamer composition that contains from about 10% to about 90%, of a microparticulated protein component and from about 10% to about 90%, of a insoluble microcrystalline cellulose component. In the hydrated state the microparticulated protein component particles have a mean diameter particle size distribution ranging from about 0.1 microns to about 10.0 microns, and preferably less than about 5 percent of the total number of particles exceed about 10.0 microns in diameter. Further, the creamer composition contains less than about 2% of fat and oil. These non-fat creamer compositions can be powdered and liquid, dairy and non-dairy, and can be prepared in both concentrated and ready-to-use forms. The powdered creamer compositions are well suited for use in instant and/or dry food and beverage compositions that require the addition of water or other suitable fluids prior to use.
Patent CA-2514879-A1 (CA)
Title: Utilisation d'un melange de deux ou de plusieurs matieres d'enrobage enteriques afin de reguler la liberation de medicaments
Inventor: SHAH NIRAJ
IPC: A61K9/20
Filed: 2004-01-05
Abstract: L'invention concerne des compositions pharmaceutiques, plus particulièrement des formes de dosage oral, contenant deux ou plusieurs matériaux de revêtement entériques, utilisés soit en tant que revêtement soit en tant que forme de dosage de matrice. L'invention concerne également des procédés de fabrication et d'utilisation de ces compositions. Les compositions de l'invention sont caractérisées en ce qu'elles contiennent un profil de libération soutenu à un pH inférieur et un profil de dissolution accélérée à un pH supérieur.
Patent CA-2516402-A1 (CA)
Inventor: SHIOMI YASUSHI
IPC: G06Q20/00
Filed: 2003-02-28
Abstract: L'invention concerne un système d'émission de points ou de coupons permettant de vendre une marchandise ou de fournir un service au rabais sans assumer le coût de la mesure d'incitation. Dans un service de point, lorsqu'un consommateur (3) achète un contenu particulier vendu par un vendeur de contenu (1), le consommateur (3) peut obtenir un rabais s'il possède un point de redevance prépayée généré lorsqu'un vendeur de marchandises (5) vend une marchandise non particulière et peut obtenir un rabais lors de l'achat d'une marchandise non particulière vendue par le vendeur de marchandises (5) s'il possède un point de redevance acquis préalablement généré lorsque le vendeur de marchandises (1) vend une marchandise particulière. Le vendeur de contenu (1) bénéficie d'un prix de vente, y compris lorsque le contenu est vendu à un prix réduit, et n'assume pas le coût de la mesure d'incitation en émettant un point.
Patent CA-2517101-A1 (CA)
Inventor: TACHAS GEORGE
IPC: C12Q1/68
Filed: 2004-02-27
Abstract: Compounds, compositions and methods are provided for modulating the expressi on of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of diseas e associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
Patent CA-2517774-A1 (CA)
Title: Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
Inventor: SLOWINSKI FRANCK
IPC: C07D487/04
Filed: 2004-03-19
Abstract: The invention relates to a substituted-pyrimidone derivative represented by formula (I) or a salt thereof, wherein: X represents two hydrogen atom, a sulfur atom, an oxygen atom or a C1-2 alkyl group and a hydrogen atom; Y  represents a bond, a carbonyl group, a methylene group optionally substituted;  R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the rings being optionally substituted; R2 represents a phenyl group or a naphthalene ring; the phenyl group and the naphthalene ring being optionally substituted; R3 represents a hydrogen atour or a C1-6 alkyl group; R4 represents a C1-2 perhalogenated alkyl group or a C1-3 halogenated alkyl group; R5 represents a hydrogen atour; a C1-6 alkyl group or a halogen atom; n represents 0 to 3; and p+q=0 to 3. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3.beta., such as Alzheimer disease.
Patent CA-2519368-A1 (CA)
Title: Statistical analysis of regulatory factor binding sites of differentially expressed genes
Inventor: MCEVOY LESLIE MARGARET
IPC: G16B20/30
Filed: 2004-03-24
Abstract: The invention concerns the statistical analysis of regulatory factor binding sites of differentially expressed genes. More particularly, the invention concerns methods for identifying and characterizing regulatory factor, e.g.  transcription factor binding sites in differentially expressed genes in order to develop therapeutic strategies for the treatment of diseased which are accompanied by differential gene expression or to study biological processes.
Patent CA-2519921-A1 (CA)
Inventor: MATSUMOTO KUNIO
IPC: A61K35/761
Filed: 2004-03-24
Abstract: A preventive or therapeutic agent for asthma, comprising HGF or its salt as an active ingredient.
Patent CA-2521937-A1 (CA)
Title: Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
Inventor: NOMAK RANA
IPC: C07D211/60
Filed: 2004-04-12
Abstract: Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Patent CA-2522690-A1 (CA)
Title: Inhibition of drug binding to serum albumin
Inventor: PETERS ROBERT T
IPC: A61K31/00
Filed: 2004-05-06
Abstract: The invention relates to improved therapeutics for treating diseases or conditions that provide greater bioavailabilty and more predictable dosing.  The invention relates to a chimeric protein comprised of a biologically active molecule linked to an Fc fragment of an immunoglobulin, wherein the chimeric protein binds less serum albumin compared to the same biologically active molecule of the chimeric protein not linked to an Fc fragment of an immunoglobulin. The invention also relates to a method of treating a disease or condition said method comprising administering a chimeric protein comprising a biologically active molecule linked to an Fc fragment of an immunoglobulin, wherein the chimeric protein binds less serum albumin compared to the same biologically active molecule of the chimeric protein not linked to an Fc fragment of an immunoglobulin
Patent CA-2523861-A1 (CA)
Title: Low loss foam composition and cable having low loss foam layer
Inventor: CHOPRA VIJAY K
IPC: C08L23/16
Filed: 2003-04-24
Abstract: The invention relates to a low loss foam composition and cable, such as a coaxial cable. The foam composition is formed by heating an olefinic polymer , such as a high density polyethylene, medium density polyethylene, low densit y polyethylene, linear low density polyethylene, polypropylene, or a combinati on thereof, into a molten state composition, optionally with a nucleating agent . The molten mixture is extruded under pressure through a die with a blowing agent comprising an atmospheric gas, such as carbon dioxide, nitrogen or air , and a co-blowing agent selected from hydrofluorocarbons, hydrochlorofluorocarbons, or perfluoro compounds, such as HFC-134a. The cabl e is formed by extruding the foam composition onto a signal carrying conductor and sheathing the foam-coated signal carrying conductor in an appropriate conducting shield.
Patent CA-2526473-A1 (CA)
Title: Garment element with an access opening
Inventor: ST-GERMAIN GILLES
IPC: A41D27/00
Filed: 2005-11-10
Abstract: In a garment element, for example a cuff for a sleeve, an access opening is defined between an overlap section extending between two attachment sections, the overlap section being formed of interleaving fabric ends suitable stiffened to provide a self-sealing function in both a use mode in which a body member extends there through and a non-use mode with the opening closed.
Patent CA-2529300-A1 (CA)
Title: Devices and methods relating to electrochemical biosensors
Inventor: SVETNIK VLADIMIR
IPC: G01N27/00
Filed: 2004-06-18
Abstract: A system for testing for analytes in a sample of biological fluid includes a test strip that defines a cavity for receiving the sample. At least two sets of electrodes are adjacent the sample cavity, including one for measuring one property of the sample, and another for measuring one or more other properties of the sample, such as temperature and/or the presence or magnitude of confounding variables. The measurements are combined to yield the desired result. At least one set of working and counter electrodes each have a plurality of elongated "fingers" interdigitated with those of the other electrode in the set. The gaps between fingers can be quite small, so that the two electrode sets together can operate in a small measurement volume of sample. Additional electrodes can be included that measure the presence or sufficiency of the sample, and additional traces on the strip can act as configuration identifiers.
Patent CA-2529605-A1 (CA)
Title: Methods and systems for the annotation of biomolecule patterns in chromatography/mass-spectrometry analysis
Inventor: BJORKESTEN LENNART
IPC: G01N30/86
Filed: 2004-07-06
Abstract: The method and measurement system according to the invention performs combined Chromatography and Mass Spectrometry analysis and comprises the steps of:  performing an C/MS analysis (300); generating at least one first elution profile (305), wherein one dimension is an elution time of the chromatography, and one dimension is mass to charge ratio (m/z), and at least one dimension a signal intensity, and the signal from each biomolecule species is dispersed forming a plurality of signal peaks associated with each biomolecule species in the elution profile; and reassembling (310) the dispersed signal originating from one biomolecule species in the elution profile. The reassembling comprises an automated annotation adapted to reassemble signal variations in the elution profile that originate from the same biomolecule species and generating a biomolecule map. The automated annotating is simultaneously based on both the elution time-dimension and the m/z-dimension.
Patent CA-2529874-A1 (CA)
Inventor: ARLANDIS MALONDA DIEGO
IPC: H04B3/54
Filed: 2004-06-04
Abstract: The invention relates to a method enabling communication nodes to access a transmission means on an electrical grid. The invention provides nodes with equal access to a shared means such as the electrical grid. In addition, the invention enables the maximum access speed to be reached when there are no collisions between reservation requests, as well as enabling coexistence signals to be robustly detected in noisy environments. The invention is characterised in that it involves the use of communication-reservation (5) and -release (10) signals and a random wait time (backoff time) before an electrical grid reservation with minimum and maximum pre-fixed values.
Patent CA-2531742-A1 (CA)
Title: Vibration load reduction system for a wind turbine
Inventor: ZHENG DANIAN
IPC: F03D1/00
Filed: 2005-12-29
Abstract: A wind turbine (10) includes a tower (18), a nacelle (16) supported at an upper end of a tower (18), a rotor (12) having at least one blade (14) and being arranged at the nacelle (16), and a vibration load reduction system (20) disposed at either the tower (18) or the nacelle (16). The vibration load reduction system (20) includes a base (24), at least two columns (22) extending from the base (24), and a flowable mass (28) located within the base (24) and the at least two columns (22).
Patent CA-2532917-A1 (CA)
Title: Aryl-condensed 3-arylpyridine compounds and use thereof for controlling pathogenic fungi
Inventor: STIERL REINHARD
IPC: C07D471/04
Filed: 2004-07-15
Abstract: The invention relates to bicyclic compounds of general formula I, wherein X, Y  independently represent N or C-R4; n stands for 1, 2, 3, 4 or 5; Rarepresents halogen, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-halogenalkyl, C1-C6-halogenalkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy or C(O)R5; R1 denotes halogen, cyano, C1-C6-alkyl, C1-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-alkinyl, C3-C8-cycloalkyl, optionally mono- or polysubstituted by alkyl and/or halogen, C5-C8 cycloalkenyl, optionally mono- or polysubstituted by alkyl and/or halogen, OR6, SR6 or NR7R8; R2 denotes halogen, cyano, C1-C6-alkyl, C1-C6-halogenalkyl, C2-C6-alkenyl, C2-C6-alkinyl, C3-C8-cycloalkyl, optionally mono- or polysubstituted by alkyl and/or halogen, C5-C8-cycloalkenyl, optionally mono-or polysubstituted by alkyl and/or halogen, OR6, SR6 or NR7R8, and R3 represents hydrogen, C1-C6-alkyl, C1-C6-halogenalkyl or C3-C6-cycloalkyl, optionally mono- or polysubstituted by alkyl and/or halogen. Said invention also relates to the agriculturally-acceptable salts of said compounds (I), plant protection agents, containing at least one compound of general formula (I) and/or one agriculturally-acceptable salt of (I) and at least one liquid or solid carrier substance, as well as a method for controlling phytopathogenic fungi.
Patent CA-2534963-A1 (CA)
Title: Oral and dental hygiene product
Inventor: BARTH ADOLF-PETER
IPC: A61Q11/00
Filed: 2004-08-24
Abstract: The invention relates to oral and dental hygiene products comprising a) a composite material containing poorly water-soluble calcium salts in the form of nanoparticulate primary particles which are between 5 and 150 nm long and have a cross-section of between 2 and 50 nm, and protein constituents selected from proteins, protein hydrolysates and protein hydrolysate derivatives, and b) between 0.1 and 9 wt. % of a cleaning agent, in relation to the total weight of the product. The inventive oral and dental hygiene product ensures an effective and long-lasting remineralisation of the surface of the tooth, and a protective cleaning action of the cleaning or polishing agent.
Patent CA-2535137-A1 (CA)
Inventor: FOLLINI JEAN-MARC
IPC: E21B49/10
Filed: 2006-02-02
Abstract: A pumping system for a downhole tool positionable in a wellbore penetrating a subterranean formation. The pumping system includes an actuator, a fluid movement source and a passive flow distribution block. The actuator has a body slidably positionable in a vessel. The body defines a first chamber and a second chamber in the vessel. The fluid movement source has at least one port for selectively moving fluid in at least two directions.  The passive flow distribution block is adapted to selectively divert fluid from the fluid movement source to one of the first and second chambers whereby the body is selectively reciprocated.
Patent CA-2537344-A1 (CA)
Inventor: YAN DAVID YUE
IPC: G01F1/66
Filed: 2004-09-03
Abstract: An optical system design for measuring the velocity of fluids flowing through pipes or other conduits is disclosed. The optical system is comprised of a means for delivering two beams through a window in the wall of the pipe, focused to two points aligned along an axis of the pipe and separated by a known distance, and means for detecting light that is scattered by particles carried in the fluid stream through a second window, that is disposed on the opposite side of the pipe. By measuring the time delay between detected signals, the velocity of the fluid can be determined. The delivered light beams are focused in a shallow cone of light and are blocked by an obstruction disposed behind the second window. The scattered light passes through an aperture behind the second window that surrounds the obscuration, and is focused on to a detector surface.
Patent CA-2537410-A1 (CA)
Title: Ophthalmic indazole comprising compositions for treating ocular hypertension
Inventor: LIU LUPING
IPC: C07F9/6558
Filed: 2004-08-31
Abstract: This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans, or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: formula (II) represents C6-10 aryl or C3-10 heterocyclyl, said aryl or heterocyclyl optionally substituted with 1-3 groups selected from Ra; Z represents (CH2)nPO(OR)(OR*).
Patent CA-2538774-A1 (CA)
Inventor: JACOBS GREGORY F
IPC: E04D1/30
Filed: 2006-03-08
Abstract: A hip, ridge or rake shingle comprised of a plurality of panels sandwiched on each panel portion side of a layer of shingle material, such that each panel portion can be folded along a fold line, and wherein tabs are provided for each panel portion, adapted to be bent backwardly upon themselves, sandwiching thickening panels therebetween. The shingles can be laid up on a hip, ridge or rake of a roof, to yield desirable thickened features.
Patent CA-2539097-A1 (CA)
Title: Steerable bit assembly and methods
Inventor: ARONSTAM PETER S
IPC: E21B10/62
Filed: 2004-09-13
Abstract: A drilling system includes a steerable bottOmhole assembly (BHA) having a steering unit and a control unit that provide dynamic control of drill bit orientation or tilt. Exemplary steering units can adjust bit orientation at a rate that approaches or exceeds the rotational speed of the drill string or drill bit, can include a dynamically adjustable articulated joint having a plurality of elements that deform in response to an excitation signal, can include adjustable independently rotatable rings for selectively tilting the bit, and/or can include a plurality of selectively extensible force pads. The force pads are actuated by a shape change material that deforms in response to an excitation signal. A method of directional drilling includes continuously cycling the position of the steering unit based upon the rotational speed of the drill string and/or drill bit and with reference to an external reference point.
Patent CA-2540790-A1 (CA)
Title: Lubrication of a hermetic carbon dioxide compressor
Inventor: DREIMAN NELIK I
IPC: F04C23/00
Filed: 2003-06-10
Abstract: A hermetic compressor for compressing refrigerant comprises a housing including at least a first and second compartment. A motor is mounted in the first compartment and a compression mechanism is located in the second compartment. Gas compressed by the compression mechanism is discharged into the second compartment. A drive shaft operatively couples the motor and the compression mechanism and a lubricating oil sump is formed in the second compartment. A discharge tube is located in the second compartment through which refrigerant gas in the second compartment exits the compressor. The discharge tube includes means for aspirating oil from the oil sump when the oil in the oil sump reaches a particular level.
Patent CA-2542722-A1 (CA)
Title: Masques destines a etre utilises dans des systemes d'administration de medicaments sous pression
Inventor: SMALDONE GERALD C
IPC: A61M16/00
Filed: 2004-10-29
Abstract: L'invention porte sur des masques destinés à être utilisés dans des applications d'administration de médicaments sous pression telles que des systèmes d'administration de médicaments par aérosol, et sur un procédé de réduction des dépôts de l'aérosol dans la région des yeux. Les masques des différentes formes d'exécution de l'invention comportent des éléments qui réduisent l'inertie du médicament en aérosol dans les zones périnasales. Ce qui entraîne une réduction de la quantité de médicament en aérosol qui est déposé dans la région des yeux par impact d'inertie, et en même temps, les éléments sont conçus pour maintenir le flux du médicament en aérosol dans le masque de sorte que ce flux soit effectivement administré dans le système respiratoire du patient.
Patent CA-2543565-A1 (CA)
Title: Use of caspase-8 inhibitors for modulating hematopoiesis
Inventor: BEN MOSHE TEHILA
IPC: A61K48/00
Filed: 2004-10-26
Abstract: A method of inhibiting hematopoiesis in a subject is provided. The method is effected by downregulating an expression or activity of caspase-8 in the subject thereby inhibiting hematopoiesis therein.
Patent CA-2544001-A1 (CA)
Title: Adjustable work surface support
Inventor: LIMA JOSE M
IPC: A47B21/03
Filed: 2004-10-28
Abstract: An adjustable work surface support for use with a primary work surface and a secondary work surface comprising primary work surface connecting means;  secondary work surface connecting means; a parallelogram link support comprising a support bar mounted to the primary work surface connecting means to define a first axis; and a pair of parallel arms, each arm attached at one end to the support bar and a second end attached to the secondary work surface connecting means to define a second axis; a connecting plate; attached adjacent one of the parallel arms to the primary and secondary work surface connecting means; having a first pivot point rotatable about the first axis and a second pivot point being rotatable about the second axis; such that when the arm is pivoted about the first axis, an angular position of the secondary work surface with respect to the primary work surface is substantially constant.